Obecabtagene autoleucel (obe-cel) for adult relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in the open-label, multi-center, global, single-arm, phase Ib/II FELIX study: The impact of bridging therapies on CAR T-cell expansion and persistence Meeting Abstract
| Authors: | Park, J. H.; Jabbour, E.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; Deangelo, D. J.; Lao-Sirieix, P.; Brugger, W.; Pule, M. A.; Shang, J.; Roddie, C. |
| Abstract Title: | Obecabtagene autoleucel (obe-cel) for adult relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in the open-label, multi-center, global, single-arm, phase Ib/II FELIX study: The impact of bridging therapies on CAR T-cell expansion and persistence |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3458 |
| Language: | English |
| ACCESSION: | WOS:001412753100023 |
| DOI: | 10.1182/blood-2024-201514 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
